Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Transcriptional activation of PPP1R14C by KLF7 unleashes CDK1 activity to promote lung squamous cell carcinoma
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 16 February 2026

Transcriptional activation of PPP1R14C by KLF7 unleashes CDK1 activity to promote lung squamous cell carcinoma

  • Lihua Xing1,
  • Chunluan Yuan2,
  • Xiaozhu Shen3 &
  • …
  • Kun Xiao4 

Scientific Reports , Article number:  (2026) Cite this article

  • 302 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Cancer
  • Cell biology
  • Oncology

Abstract

Lung squamous cell carcinoma (LUSC) is a lethal malignancy with a stark lack of targeted therapies, demanding the identification of novel molecular drivers. Here, we identify Protein Phosphatase 1 Regulatory Subunit 14C (PPP1R14C), an endogenous inhibitor of Protein Phosphatase 1 (PP1), as a pivotal oncogenic driver in LUSC. Integrative multi-omics analyses revealed consistent PPP1R14C overexpression in LUSC, which correlated with advanced tumor stage and poor patient survival. Mechanistically, we establish that the transcription factor KLF7 directly binds the PPP1R14C promoter to drive its expression. We demonstrate that PPP1R14C executes its pro-tumorigenic function by physically interacting with and inhibiting the PP1 catalytic subunit, thereby preventing the dephosphorylation and inactivation of CDK1. This sustained CDK1 hyperactivation fuels LUSC cell proliferation, invasion, and in vivo tumorigenesis. Critically, pharmacological inhibition of CDK1 completely abrogates the oncogenic phenotypes conferred by PPP1R14C. Our findings delineate a novel and actionable KLF7–PPP1R14C–PP1–CDK1 signaling cascade essential for LUSC pathogenesis, positioning PPP1R14C as both a prognostic biomarker and a compelling therapeutic target.

Similar content being viewed by others

Metabolic profiles of squamous cell lung carcinoma and diagnostic model construction

Article Open access 30 September 2025

A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma

Article Open access 11 August 2022

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients

Article Open access 01 December 2022

Data availability

The datasets analysed during the current study are available in the Gene Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo) repository, [project IDs: GSE92507 and GSE40827].

References

  1. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249. https://doi.org/10.3322/caac.21660 (2021).

    Google Scholar 

  2. Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73(1), 17–48. https://doi.org/10.3322/caac.21763 (2023).

    Google Scholar 

  3. Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553(7689), 446–454. https://doi.org/10.1038/nature25183 (2018).

    Google Scholar 

  4. Cancer Genome Atlas Research N. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 489(7417), 519–525. (2012). https://doi.org/10.1038/nature11404

  5. Skoulidis, F. & Heymach, J. V. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nat. Rev. Cancer 19(9), 495–509. https://doi.org/10.1038/s41568-019-0179-8 (2019).

    Google Scholar 

  6. Yuan, S., Norgard, R. J. & Stanger, B. Z. Cellular plasticity in cancer. Cancer Discov. 9(7), 837–851. https://doi.org/10.1158/2159-8290.Cd-19-0015 (2019).

    Google Scholar 

  7. Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12(1), 31–46. https://doi.org/10.1158/2159-8290.Cd-21-1059 (2022).

    Google Scholar 

  8. Matthews, H. K., Bertoli, C. & de Bruin, R. A. M. Cell cycle control in cancer. Nat. Rev. Mol. Cell Biol. 23(1), 74–88. https://doi.org/10.1038/s41580-021-00404-3 (2021).

    Google Scholar 

  9. Suski, J. M., Braun, M., Strmiska, V. & Sicinski, P. Targeting cell-cycle machinery in cancer. Cancer Cell 39(6), 759–778. https://doi.org/10.1016/j.ccell.2021.03.010 (2021).

    Google Scholar 

  10. Grallert, A. et al. A PP1-PP2A phosphatase relay controls mitotic progression. Nature 517(7532), 94–98. https://doi.org/10.1038/nature14019 (2015).

    Google Scholar 

  11. Yang, X. et al. Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation. Nat. Commun. 15(1), 2089. https://doi.org/10.1038/s41467-024-46358-w (2024).

    Google Scholar 

  12. Tetreault, M. P., Yang, Y. & Katz, J. P. Krüppel-like factors in cancer. Nat. Rev. Cancer 13(10), 701–713. https://doi.org/10.1038/nrc3582 (2013).

    Google Scholar 

  13. Liu, Q. R. et al. KEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphine. J. Biol. Chem. 277(15), 13312–13320. https://doi.org/10.1074/jbc.M107558200 (2002).

    Google Scholar 

  14. Jian, Y. et al. Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple-negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta. Clin. Transl. Med. 12(1), e725. https://doi.org/10.1002/ctm2.725 (2022).

    Google Scholar 

  15. Gupta, R. et al. KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity. Proc. Natl. Acad. Sci. U. S. A. 117(22), 12341–12351. https://doi.org/10.1073/pnas.2005156117 (2020).

    Google Scholar 

  16. Häfner, J., Mayr, M. I., Möckel, M. M. & Mayer, T. U. Pre-anaphase chromosome oscillations are regulated by the antagonistic activities of Cdk1 and PP1 on Kif18A. Nat. Commun. 5, 4397. https://doi.org/10.1038/ncomms5397 (2014).

    Google Scholar 

  17. Aarts, M. et al. Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1. Cancer Discov. 2(6), 524–539. https://doi.org/10.1158/2159-8290.Cd-11-0320 (2012).

    Google Scholar 

  18. Hong, W. et al. Krüppel-like factor 7 deficiency disrupts corpus callosum development and neuronal migration in the developing mouse cerebral cortex. Brain Pathol. 33(5), e13186. https://doi.org/10.1111/bpa.13186 (2023).

    Google Scholar 

  19. Yang, X. et al. KLF7 promotes adipocyte inflammation and glucose metabolism disorder by activating the PKCζ/NF-κB pathway. FASEB J. 37(7), e23033. https://doi.org/10.1096/fj.202300005R (2023).

    Google Scholar 

  20. Wurzenberger, C. & Gerlich, D. W. Phosphatases: Providing safe passage through mitotic exit. Nat. Rev. Mol. Cell Biol. 12(8), 469–482. https://doi.org/10.1038/nrm3149 (2011).

    Google Scholar 

  21. Felgueiras, J., Jerónimo, C. & Fardilha, M. (2020) Protein phosphatase 1 in tumorigenesis: Is it worth a closer look?. Biochim. Biophys. Acta Rev. Cancer 2, 188433. https://doi.org/10.1016/j.bbcan.2020.188433 (1874).

    Google Scholar 

  22. Su, P. L. et al. Recent advances in therapeutic strategies for non-small cell lung cancer. J. Hematol. Oncol. 18(1), 35. https://doi.org/10.1186/s13045-025-01679-1 (2025).

    Google Scholar 

  23. Relli, V., Trerotola, M., Guerra, E. & Alberti, S. Abandoning the notion of non-small cell lung cancer. Trends Mol. Med. 25(7), 585–594. https://doi.org/10.1016/j.molmed.2019.04.012 (2019).

    Google Scholar 

  24. Ogden, J. et al. A human model to deconvolve genotype-phenotype causations in lung squamous cell carcinoma. Nat. Commun. 16(1), 3215. https://doi.org/10.1038/s41467-025-58343-y (2025).

    Google Scholar 

  25. Zhu, Z., Hu, E., Shen, H., Tan, J. & Zeng, S. The functional and clinical roles of liquid biopsy in patient-derived models. J. Hematol. Oncol. 16(1), 36. https://doi.org/10.1186/s13045-023-01433-5 (2023).

    Google Scholar 

  26. Srivastava, G. et al. The ribosomal RNA processing 1B: Protein phosphatase 1 holoenzyme reveals non-canonical PP1 interaction motifs. Cell Rep. 41(9), 111726. https://doi.org/10.1016/j.celrep.2022.111726 (2022).

    Google Scholar 

Download references

Funding

This study was supported by the Lianyungang Ageing Health Research Project (L202304), the Lianyungang Traditional Chinese Medicine Science and Technology Development Program Project (ZD202310), the XZHMU-QL Joint Research Fund (QL-YB045), the Lianyungang Municipal Science and Technology Program Project (JCYJ2526), and the Wu Jieping Medical Foundation Research Program (320.6750.2025-28-2).

Author information

Authors and Affiliations

  1. Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China

    Lihua Xing

  2. Department of Oncology, The First People’s Hospital of Lianyungang, Lianyungang, 222000, Jiangsu, China

    Chunluan Yuan

  3. Department of Geriatrics, Lianyungang Second People’s Hospital, Lianyungang, 222005, China

    Xiaozhu Shen

  4. Department of Family Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China

    Kun Xiao

Authors
  1. Lihua Xing
    View author publications

    Search author on:PubMed Google Scholar

  2. Chunluan Yuan
    View author publications

    Search author on:PubMed Google Scholar

  3. Xiaozhu Shen
    View author publications

    Search author on:PubMed Google Scholar

  4. Kun Xiao
    View author publications

    Search author on:PubMed Google Scholar

Contributions

L.X and C.Y. contributed to the data research. K.X designed the study. C.Y assisted in report preparation. X.S and K.X supervised the study. All authors have read and approved the final manuscript.

Corresponding authors

Correspondence to Xiaozhu Shen or Kun Xiao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval and consent to participate

All animal experiments were conducted in accordance with the guidelines and regulations set forth by the Experiment Ethics Review Committee of Lianyungang Second People’s Hospital.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xing, L., Yuan, C., Shen, X. et al. Transcriptional activation of PPP1R14C by KLF7 unleashes CDK1 activity to promote lung squamous cell carcinoma. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39174-3

Download citation

  • Received: 22 September 2025

  • Accepted: 03 February 2026

  • Published: 16 February 2026

  • DOI: https://doi.org/10.1038/s41598-026-39174-3

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Lung squamous cell carcinoma (LUSC)
  • PPP1R14C
  • KLF7
  • CDK1
  • Oncogene
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer